![]() |
|
|

*
Division of Nutritional Sciences and Department of Food Science and Human Nutrition, University of Illinois, Urbana-Champaign, IL 61801;
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215; and
**
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Division of Hematology and Oncology, The Ohio State University, Columbus, OH 43210-1240
4To whom correspondence should be addressed.
Epidemiologic and animal studies provide support for a relationship between high intakes of carotenoids from fruits and vegetables with reduced risk of several malignancies including prostate cancer. The highly controlled environments of in vitro systems provide an opportunity to investigate the cellular and molecular effects of carotenoids. The effects of ß-carotene (BC) on in vitro growth rates, p21WAF1 and p53 gene expression, as well as the conversion of BC to retinol were investigated in three human prostate adenocarcinoma cell lines: PC-3, DU 145 and LNCaP. In these experiments, media concentrations of 30 µmol BC/L for 72 h significantly (P < 0.05) slowed in vitro growth rates in all three cell lines, independently of p53 or p21WAF1 status or expression. 14C-labeled retinol was detected in prostate tumor cells incubated with 14C-labeled BC, suggesting metabolic conversion of BC to retinol. Conversely, no 14C-labeled retinol was detected in media incubated without prostate cancer cells. These studies support a hypothesis that in vitro biological effects of BC on prostate cells may result in part from the conversion of BC to retinol or other metabolites. The possibility that prostate cancer cells in vivo locally metabolize provitamin A carotenoids to retinol and other related metabolites may have implications for our understanding of prostate cancer etiology and the design of future prevention studies.
KEY WORDS: prostate cancer ß-carotene vitamin A retinoids cell culture
This article has been cited by other articles:
![]() |
V. A. Kirsh, S. T. Mayne, U. Peters, N. Chatterjee, M. F. Leitzmann, L. B. Dixon, D. A. Urban, E. D. Crawford, and R. B. Hayes A Prospective Study of Lycopene and Tomato Product Intake and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 92 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Campbell, K. Canene-Adams, B. L. Lindshield, T. W.-M. Boileau, S. K. Clinton, and J. W. Erdman Jr Tomato Phytochemicals and Prostate Cancer Risk J. Nutr., December 1, 2004; 134(12): 3486S - 3492S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Prakash, C. Liu, K.-Q. Hu, N. I. Krinsky, R. M. Russell, and X.-D. Wang {beta}-Carotene and {beta}-Apo-14'-Carotenoic Acid Prevent the Reduction of Retinoic Acid Receptor {beta} in Benzo[a]pyrene-Treated Normal Human Bronchial Epithelial Cells J. Nutr., March 1, 2004; 134(3): 667 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wu, J. W. Erdman Jr., S. J. Schwartz, E. A. Platz, M. Leitzmann, S. K. Clinton, V. DeGroff, W. C. Willett, and E. Giovannucci Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W.-M. Boileau, Z. Liao, S. Kim, S. Lemeshow, J. W. Erdman Jr., and S. K. Clinton Prostate Carcinogenesis in N-methyl-N-nitrosourea (NMU)-Testosterone-Treated Rats Fed Tomato Powder, Lycopene, or Energy-Restricted Diets J Natl Cancer Inst, November 5, 2003; 95(21): 1578 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wilkinson and G. W. Chodak Critical Review of Complementary Therapies for Prostate Cancer J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. van Gils, R. M. Bostick, M. C. Stern, and J. A. Taylor Differences in Base Excision Repair Capacity May Modulate the Effect of Dietary Antioxidant Intake on Prostate Cancer Risk: An Example of Polymorphisms in the XRCC1 Gene Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1279 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Hadley, E. C. Miller, S. J. Schwartz, and S. K. Clinton Tomatoes, Lycopene, and Prostate Cancer: Progress and Promise Experimental Biology and Medicine, November 1, 2002; 227(10): 869 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Y. Kedishvili, O. V. Chumakova, S. V. Chetyrkin, O. V. Belyaeva, E. A. Lapshina, D. W. Lin, M. Matsumura, and P. S. Nelson Evidence That the Human Gene for Prostate Short-chain Dehydrogenase/Reductase (PSDR1) Encodes a Novel Retinal Reductase (RalR1) J. Biol. Chem., August 2, 2002; 277(32): 28909 - 28915. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Palozza, S. Serini, N. Maggiano, M. Angelini, A. Boninsegna, F. Di Nicuolo, F. O. Ranelletti, and G. Calviello Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by {beta}-carotene through down-regulation of cyclin A and Bcl-2 family proteins Carcinogenesis, January 1, 2002; 23(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kotake-Nara, M. Kushiro, H. Zhang, T. Sugawara, K. Miyashita, and A. Nagao Carotenoids Affect Proliferation of Human Prostate Cancer Cells J. Nutr., December 1, 2001; 131(12): 3303 - 3306. [Abstract] [Full Text] [PDF] |
||||